When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GWPH - GW Pharmaceuticals Facing Some Problems In Europe
GW Pharmaceuticals Plc
GW Pharmaceuticals (NASDAQ:GWPH) has had a very successful launch of "Epidiolex" in the USA. This, along with its promising pipeline, has been the main reason for the stock price gains it had enjoyed this year.
However, recent news that the U.K. NHS (National Health Service) would not currently approve Epidiolex (or "Epidyolex" as it is trademarked in Europe) represent a barrier to their monetisation plans for Europe.
The news means Epidiolex will not be available in the U.K. in the short to medium term even after EMA approval. Costing model problems may apply